GHOLAMREZA POURMAND
Current Position: Dean of Sina University Hospital
Tehran University of Medical Sciences
Contact Information:
Academic Rank:Full Professor[Full GMC Registration (UK): 2876340]
Department:Urology
Address: Imam Khomeini St., Hassan Abad Sq., Sina Hospital
Tel (Office): (+9821) 6634 8560
Fax: (+9821) 6634 8561
E-mail:gh_pourmand@yahoo.com
Education:
1992 – 1993
Fellowship in “Renal Transplantation”
Middlesex Hospital
London – UK
1984 – 1985
Fellowship in “Male Infertility & Urologic Oncology”
University of California Los Angeles (UCLA)
California - USA
1974 – 1978
Course of Specialty in “General Surgery & Urology”
Tehran University of Medical Sciences
Tehran – Iran
1965 – 1972
General Medicine (MD)
Ahvaz University of Medical Sciences
Ahvaz – Iran
Further Training Courses:
August 2-4, 2010
AkademiKA Program about "Principles of Good Clinical Practice",
Turkey
May 15-18, 2006
Nanomedicine (Short Visit), Moscow – Russia
March 10-18, 2006
Nanomedicine (Short Course), Moscow – Russia
1998
Reproductive (Short Course), Brussels – Belgium
1992-1993
Laparoscopic Urology, King’s College School of Medicine and
Dentistry, UK
1992-1993
Renal transplantation, Middlesex Hospital, London – UK
1984Male infertility, 3 months, U.C.L.A., U.S.A.
1984Urology Oncology and Pediatric Urology, 6 months, Buffalo & U.C.L.A., U.S.A.
1984Renal Transplantation, 3 months, Guy’s Hospital, London – UK
1982Neurogenic Bladder(Short Course), West Germany
1977A Short Course of Urology & Nephrology, 3 months, Institute of Urology& Nephrology,
London – UK
Highlighted Educational/Professional Qualifications:
 The 3rdFestival of Eternal Faces, 2006
Professional Society Membership:
1990 – Present
The European Association of Urology
1988 – Present
The American Urologic Association (Corresponding Member)
1988 – Present
The International Society of Urology (Iranian Delegate)
1972 – Present
The Iranian Medical Council
Work Experience:
Executive Activities

2010:Head of the Specialized Committee of Surgical, Clinical Sciences, 16thRazi Medical
Sciences Research Festival

2010:Member of Examining Board of Oral OSCE, 57th Urology Board Examination

2005 – Present: The Secretary General of Clinical Research Committee, The 11thFestival
of National Research Center of Medical Sciences of Iran

2005 - Present: Dean of Sina University Hospital

2005:Member of Distinguished Iranian Professors

2003 - Present:Director of Urology Research Center, Tehran University of Medical
Sciences

2003 – Present:Member of Nanotechnology Committee, Ministry of Health, Treatment
and Medical Education

2002 – Present:Iranian Councilor for the Middle East Organ Transplantation Society

2001 – Present:Member of Clinical Sciences Committee, Ministry of Health, Treatment
andMedical Education

2001 – Present:Member of Medical Instruments Committee, Ministry of Health,
Treatment and Medical Education

2000 – Present: Consultant Member of the Academy of Medical Sciences

1990 – Present: Member of the Counseling Board of the Medical Journal of Islamic
Republic of Iran

1990 – Present:Member of the European Association of Urology

1989 – Present:Professor Delegate of SIU

1988 – Present:Corresponding member of the American Urological Association

1980 – Present: Member of the Supreme Medical Council, Ministry of Health

2001:Clinical Sciences Research Programming Committee, Ministry of Health,
Treatment and Medical Education

1993 – 1997:Vice Chancellor for Research, Tehran University of Medical Sciences

1990 – 1992:Secretary General of the Iranian Kidney Transplant Foundation

1990 – 1993:Member of the American Fertility Society

1990 – 1992:Deputy Dean in Research, Tehran Medical Faculty

1988 – 1992: Chairman of Urology Department, Tehran University – Medical Faculty

1985 – 1993:Head of Urology Department, Sina University Hospital

1982 – 1985: Vice – Chairman of the Iranian Urological Association
Editorial Activities

Editorial board member of the Iranian Journal of Reproductive Medicine (2004)

Editorial board member of Pejouhesh Journal of the Faculty of Medicine (2000)

Urology journal official of the Journal of the Urology and Nephrology Research Center
and the Iranian Urological Association (2002)

Editor of Acta Medical Iranica, Medical Journal of Tehran University (1990-1997)

Editorial board member of ActaMedicaIranica (1976)

Editorial board member of the Medical Journal of Tehran University of Medical Sciences
(1976)

Editorial board member of the Iranian Journal of Reproductive Medicine
Clinical Activities
1978 – Present
SINA UNIVERSITY HOSPITAL
Urologist
Tehran – Iran
1972 – 1974
AIR FORCE (Military Service)
1st Lieutenant – General Practitioner
Tehran – Iran
Teaching Service
1995 – Present
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Full Professor
Tehran – Iran
1986 – 1994
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Associate Professor
Tehran – Iran
1978 – 1986
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Assistant Professor
Tehran – Iran
Thesis:
1. Sajadi H, Evaluating erectile dysfunction treatment in andropause men considering
plasma testosterone levels in patients referred to Sina Hospital (2009-2010), Specialty
course of “Urology Surgery”, April 2011 (Advisor)
2. Hedayatifar SH, Evaluating clinical trend, results and outcomes of kidney transplant in
patients operated in Sina Hospital (1999-2008), Specialty course of “Urology Surgery”,
June 2010 (Advisor)
3. Mansouri S, Evaluatingvaginal delivery urologic complications, Specialty course of
“Urology Surgery”, 2010 (Consultant)
4. Shaeikh-al-Eslami, Evaluating the effect of pentoxifilinon clinical signs and IL-6
decrease following torsion in male rats and comparing it to control group, General
Medicine, 2008 (Consultant)
5. Allameh F, Evaluating the effect of sex hormones in the incidence of prostate cancer,
General Medicine, 2009 (Advisor)
6. MohseniLangroudi M, Evaluating the effect of meat, garlic and tomato (licopen) on
prostate cancer,General Medicine, 2009(Advisor)
7. Ranjbar M, Evaluating the number of IFN-γ, IL-10, IL-17 cytokine secreting cells and
determining the percentage of subcategories of T-adjusting cells
(CD4+CD25+FoxP3+CD3+CD8+CD28-) in kidney transplant patients,"Immunology"
MSc. thesis, 2010 (Advisor)
8. Solgi GH, Effect of injecting donor's bone marrow cells on chimerism and renal
transplant outcome prognosis, "Immunology" PhD dissertation,2010 (Consultant)
9. Mahdiani M, Evaluating the relationship between hs-CRP serum level and renal graft
survival during the first post-kidney-transplant year in Sina Hospital in the second fall
and winter, 2007, Specialty course of “Urology Surgery”,2010 (Consultant)
10. Daneshpajouh A, Evaluating the treatment effects of intra-prostate toxin botulinum
Type A injection in prostate benign hyperplasia, Specialty course of “Urology Surgery”,
2009 (Consultant)
11. Shahnazari A, Evaluating predictive factors for the presence of a motile sperm in
testicles of non-obstructiveazoospermic patients, Specialty course of “Urology
Surgery”,June 2010 (Advisor)
12. Hosseini, M, Evaluating the effect of corrected calcium levels on the incidence of
prostate cancer, General Medicine, 2010 (Advisor)
13. Shokouhideh V, Evaluating the relationship between erectile disorders and risk factors
in patients with coronary vascular disease among patients referred to the angiography
department of Day General Hospital (2008), Specialty course of “Urology Surgery”,
2010 (Advisor)
14. Family P, Ahmadi H, Evaluating the effect of vasectomy, sexual behaviors and
infections of the urinary system on the incidence of prostate cancer, General Medicine,
2008 (Advisor)
15. Abedi AR, Studying prostates cancer progress and prognosis based on PTEN, PSA and
Gleason Score, Specialty course of “Urology Surgery”, 2007 (Advisor)
16. Goudarzi M, Evaluating the effect of pentoxyphyllin on clinical signs and the
comparison of the reduction rate of TNF a after torsion in male rats and a control
group, General Medicine, 2007 (Consultant)
17. Khansari M, Evaluating the effect of estrogenic, progesterone and androgenic
recipients on progress and prognosis of bladder cancer and their relationship in
patients referred to Sina, Shariati and Imam Khomeini Hospitals (March 2001 –
October 2005), General Medicine, 2007 (Advisor)
18. Ghobadi E, Afshar M, Evaluating the effect of low power helium-neon laser on
secretion rate of effective cytokines of chronic transplantation pain in a culture gel,
General Medicine, 2007 (Advisor)
19. Salahi M, MohseniLangroudi M, Evaluating the effect of 17 risk factors on the
incidence of prostate cancer in Isfahan province, General Medicine, 2007 (Advisor)
20. Hosseini M, Evaluating the effect of modified amounts of calcium on the incident of
prostate cancer, General Medicine, 2007 (Advisor)
21. Sabouri B, Evaluating the effect of 16 risk factors on the incidence of prostate cancer,
General Medicine, 2007 (Advisor)
22. Ghorbani A, Searching mutations in agxt among Iranian patients suspicious of a type
of primary hyperoxaluria, Master’s Degree, 2006 (Consultant)
23. Naseh HR, Comparing urine facilitators, blockers and proteins of patients having renal
stones with healthy people (2002), Specialty course of “Urology Surgery”, 2005
(Advisor)
24. Mousavi SH, Comparing sexual impotency in groups including healthy people, patients
with renal dysfunction undergoing hemodialysis and kidney transplant recipients,
Specialty course of “Urology Surgery”, 2005 (Advisor)
25. Seraji A, The retrospective study of the role of microchimerism in graft survival of
female recipients who received kidney from males in Sina Kidney Transplant Research
Center (Sina Hospital) (1993-2002), Specialty course of “Urology Surgery”,
2003(Advisor)
26. Salem S, Evaluating the prevalence of infections during the 1st year following kidney
transplant in 100 cases in Sina Hospital (2002-2003), General Medicine, 2003(Advisor)
27. Jalalizadeh B, Evaluating the stability of chromatin in infertile patients with spinal and
vascular lesions (varicocell) and healthy males referred to MirzaKouchak Khan and
Sina Hospitals and Kosar Medical Center (2002-2003), Specialty course of “Urology
Surgery”, 2003 (Advisor)
28. Sina A, The study of Y-chromosome microdeletion in patients referred to Sina and
MirzaKhouchak Khan Hospitals with non-onstructive idiopathic azospermia (19992000), Specialty course of “Urology Surgery”, 2002 (Advisor)
29. Jaladat H, Studying the prevalence of anti-sperm antibody (IgA, IgG) in serum and
semen of patients with varicocell referred to Sina Hospital in 2002 before and 6months
after varicocelectomy, Specialty course of “Urology Surgery”, 2002 (Advisor)
30. Baradaran N, Evaluating the effect of developing diabetes on the incidence of prostate
cancer, General Medicine, 2002 (Advisor)
31. Shoari M, Evaluating the frequency of diabetes mellitus or its increase following
kidney transplant and the how’s of its distribution according to some suggested factors
in patients operated in Sina Hospital (2007-2009), General Medicine, 2001 (Advisor)
32. Hashemian E, Evaluating the bone density in patients with kidney stone and comparing
the results with a control group, General Medicine, 2001 (Advisor)
33. Sadri M, Evaluating the effect of varicocelectomy on exact sperm morphology of
patients referred to Sina Hospital with varicocell (1998-2000), Specialty course of
“Urology Surgery”, 2000 (Advisor)
34. Haghshenas KH, Evaluating prognostic factors following Vedns surgery in
Venogenomicempote patients in Sina Hospital (1993-1998), Specialty course of
“Urology Surgery”, 1998 (Advisor)
35. ZohrehvandR, Comparing the quality of sperm test and the amount of sexual hormones
before and after kidney transplant in male receivers operated in Sina Hospital (19981999), Specialty course of “Urology Surgery”, 1998 (Advisor)
36. Amidi A, Evaluating kidney damages by NAG and AAP urinary enzymes in patients
treated by ESWL, Specialty course of “Urology Surgery”, 1996 (Advisor)
37. Taheri M, Studying therapeutical effects of PygeumAfricanum essence on prostate
adenoma in Sina Hospital, Specialty course of “Urology Surgery”, 1996 (Advisor)
38. Afshar K, Evaluating serum lipoprotein changes in kidney transplant, Specialty course
of “Urology Surgery”, 1995 (Advisor)
39. Hematian MA, Evaluating kidney function after breaking the stones using renogram,
radionuclide and DTPA, Specialty course of “Urology Surgery”, 1995(Advisor)
40. KalhoriSH, The bacteriological evaluation of the central core of renal stones, Specialty
course of “Urology Surgery”, 1994 (Advisor)
41. Mokhtari GH, Urologic complications of gynecological surgeries, Specialty course of
“Urology Surgery”, 1993(Advisor)
42. Eshraghi B, The effect of diagnosis & treatment of papaverine in treating male
infertility, Specialty course of “Urology Surgery”, 1991 (Advisor)
43. Afshar K, Evaluating ESWL results performed in Sina Hospital ,General Medicine,
1991 (Advisor)
44. JamaliPaghal’e M, Pyeloplasty and comparing Tubating Vs. Tubeless surgical methods
in its treatment, Specialty course of “Urology Surgery”, 1991(Advisor)
45. Rafie B, Analyzing chemical renal stones (1987-88), General Medicine, 1988 (Advisor)
Research Interests:

Nanotechnology

Prostate Cancer

Kidney Transplantation
Research Projects:
Ongoing

Comparison of cut-off value for total prostate-specific antigen and free to total
prostate-specific antigen ratio with international standards in s multi-centric study

Study of erectile dysfunction treatment in andropause patients according to serum
testosterone level
Completed

Plasma adiponectin concentration before and after kidney transplantation

The evaluation of clinical and laboratory changes after varicocelectomy

Prostate cancer in Iran, risk factors

CMV in transplanted kidney

The role of microchimerism in graft survival of female recipients who received
kidney from males (aretrospective study), November 1993 – August 2002

“Erectile Dysfunction in patients with coronary artery disease andrisk of coronary
artery disease in patients with erectile dysfunction", is there any correlation?

The incidence of infection in the first year after renal transplantation in 100 patients
in Sina hospital

Evaluating the progression and outcome of prostate carcinoma with regard to PSA,
Gleason score and PTEN gene

The prevalence of urinarytract infection before and after simple prostatectomy
(TURP, open)

The population based evaluation of correlation between risk factors and prostate
cancer [Multi centric case–control study]

Evaluating the efficacy of Nandrolone (injectable androgen)in decreasing
bothersome symptoms after surgery for BPH

The evaluation of progression of prostate carcinoma based on Gleason score and
pathologic stage

Study and comparison of effects of living donor bone marrow cells infusion on
kidney recipient and graft survival with control group.
Publications:

Articles
 English
1. Razeghi E, Shafipour M, Ashraf H, Pourmand G. Lipid disturbances before and after
renal transplant. Exp Clin Transplant., 9 (4): 230-5, August 2011 [PMID:21819366]
2. Hadadi A, Pourmand G, Mehdipour-Aghabagher B. Unilateral testicular tuberculosis:
Case report. Andrologia, 9 (4): 230-5, May 26, 2011 (doi: 10.1111/j.14390272.2010.01097.x.) [PMID:21615454]
3. Salem S, Salahi M, Mohseni M, Mehrsai AR, Jahani Y, Pourmand G. Major dietary
factors and prostate cancer risk: A prospective multi-cancer case-control
study.Nutrition & Cancer, 00 (0): 1-7 ,November 22, 2010 & Nutr Cancer, 63(1):21-7,
January 2011
4. Pourmand G, Solgi GH. Augmentation of chimerism by donor bone marrow cells
infusion in kidney allograft recipients. European Urology Supplements, 10 (2): 134,
2011
5. Mirfakhraie R, Kalantar SM, Mirzajani F, Montazeri M, Salsabili N, Houshmand M,
Hashemi-Gorji F,Pourmand G.A Novel Mutation in the Transactivation-Regulating
Domain of the Androgen Receptor in a Patient with Azoospermia. J Androl., December
2, 2010 [PMID:21127309]
6. Ahmadi H, Allameh F, Baradaran N, MontaserKouhsari L, BazarganHejazu SH, Salem
S, Mehrsai AR, Pourmand G. Circulating sex hormones play no role in the association
between sexual activity and the risk of prostate cancer .J Sex Med, November 22, 2010
(doi: 10.1111/j.1743-6109.2010.02115.x.) [PMID:21091879]
7. Razeghi E, Heydarian P, Amerian M, Pourmand G. The risk factors for diabetes
mellitus after kidney transplantation.Saudi J Kidney Dis Transpl., 21(6): 1038-1043,
November 21, 2010 [PMID:21060170]
8. Mirfakhraie R., Mirzajani F., Kalantar M., Montazeri M., Salsabili N.,Pourmand G.,
HoushmandM.High prevalence of AZFbmicrodeletion in Iranian patients with
idiopathic non-obstructive azzospermia.Indian J Med Res. P. 256-270, September 2010
9. Pourmand G, Seraji A., Dehghani S., Mehrsai A., Nikoobakht M., Talibnajad M.,
Razeghi E., Rahbar M., Hosseini H., Pourmand N., Poumand Sh., Zahedikia M.,
Porhussein M., Heidari F. Should post-kidney transplantation hyperlipidemia
considered a risk factor for graft function?International Journal of Organ
Transplantation Medicine. Vol. 1, No. 3, July 2010
10. Nikoobakht M, Daneshpajooh A, Ahmadi H, Namdari F, Rezaeidanesh M, Amini
S,Pourmand G. Intraprostatic botulinum toxin type A injection for the treatment of
benign prostatic hyperplasia: Initial experience with Dysport.Scand J
UrolNephrol.,44(3):151-7, April 2010[PMID:20201752]
11. Salem S, Mehrsai A, Zartab H, Shahdadi N,Pourmand G. Effect of Penile-Extender
Device in Increasing Penile Size in Men with Shortened Penis: Preliminary
Results.Urol Res.,April 2010[Epub: December 17, 2010; PMID:20016885]
12. Solgi G, Pourmand G, Mehrsai A, Taherimahmoudi M, Nicknam MH, Ebrahimi Rad
MR, Seraji A, Asadpoor A, Ansaripor B, Nikbin B, Amirzargar A. Anti-HLA antibodies
and kidney allograft outcomes in recipients with donor bone marrow cell infusion.Iran
J Immunol.,7(1):18-29, March 2010[PMID:20371916]
13. Pourmand G, Abedi AR, Karami AA, Khashayar P, Mehrsai AR. Urinary infection
before and after prostatectomy.Saudi J Kidney Dis Transpl.,21(2):290-4, March
2010[PMID:20228515]
14. Nikoobakht M, Shahnazari A, Rezaeidanesh M, Mehrsai A,Pourmand G. Effect of
Penile-Extender Device in Increasing Penile Size in Men with Shortened Penis:
Preliminary Results.J Sex Med.,January 19, 2010[PMID:20102448]
15. Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan-Pezeshki M,Pourmand G.
Erectile dysfunction severity as a risk predictor for coronary artery disease.J Sex
Med.,December 06, 2009 [Epub: September30, 2009; PMID:19796020]
16. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V,Pourmand G,
Mohagheghi MA, Abdollahzade S, Mousavi-Jarrahi A.Antibody response to
pneumococcal capsular polysaccharide vaccination in patients with chronic kidney
disease.Eur Cytokine Netw.,20(2):69-74, June 2009 [PMID:19541592]
17. Mehrsai A., Afsharpad M.I.,Afsharpad M.A.,MohydinM., AnsariB., Pourmand G.,
Nikbin B. The effect of low-level helium-neon (HeNe) laser radiation on the secretion
of cytokines that promote chronic graft rejection – An in vitro study.Medical Laser
Application, March 2009
18. Pourmand, G. Anabolic-androgenic steroid effects on early morbid symptoms after
open prostectomy: A pilot study. Aging Male. 11 (3): 123-7, September 2008
[PMID:18821287]
19. Pourmand, G. The effect of successful renal transplantation on erectile dysfunction.
The Journal of Urology. Vol. 179,No. 4,Supplement:691,May 21, 2008
20. Pourmand G. Extracorporeal shock wave lithotripsy and its effect on renal
functionassessed by 99m Technetium Dethylene-TiaminePentaaceticacidScintigraphy.The Journal of Urology. Vol. 179,No.
4,Supplement:464,May 20, 2008
21. Karimianpour N, Mousavi-Shafaei P, Ziaee AA, Akbari MT,Pourmand G, Abedi A,
Ahmadi A, AfshinAlavi H.Mutations of RAS gene family in specimens of bladder
cancer.Urol J.,5(4):237-42, Fall 2008 [PMID:19101897]
22. Pourmand G, Salem S, Moradi K, Nikoobakht MR, Tajik P, Mehrsai A. Serum Selenium
level and prostate cancer: a case-control study. Nutrition & Cancer. 60 (2): 171 – 176,
2008[PMID:18444148]
23. Pourmand, G. Extracorporeal shock wave lithotripsy in adults:results and short-term
complications.EurUrol Suppl., 7(3):81, 2008
24. PourmandG. Infectious complications after kidney transplantation: a single-center
experience.Transpl Infect Dis., 9(4):302-9,December 2007
25. Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, Roshani A,
Kheirollahi A, Kalantar E, Baradaran N, Saboury B, Allameh F, Karami A, Ahmadi H,
Jahani Y.The Risk Factors of Prostate Cancer: A Multicentric Case-Control study in
Iran. Asian Pacific Journal of Cancer Prevention, 8(3):422-8, July – September 2007
[PMID: 18159981]
26. Pourmand G. The risk factors and laboratory diagnostics for post renal transplant
Tuberculosis: a case-control, country-wide study on definitive cases.Transpl Infect Dis.
Jul 26, 2007
27. Pourmand G. Does donor nephron mass have any impact on graft survival?
Transplant Proc., 39(4):914-6,May 2007
G.Microchimerism
28. Pourmand
and
renal
transplantation:
doubt
still
persists.Transplant Proc., 39(4):948-50,May 2007
29. Pourmand G. Clinical manifestation, laboratory findings, and the response of
treatment
in
kidney
transplant
recipients
with
CMV
infection.Transplant
Proc.,39(4):993-6,May2007
30. Pourmand G.
hemodialysed
Does renal transplantation improve erectile dysfunction in
patients?
What
is
the
role
of
associated
factors?Transplant
Proc.,39(4):1029-32,May2007
31. Pourmand, G. Pelvic nerve neuropathy after kidney transplantation.Transplant Proc.,
39(4):1108-10,May 2007
32. Pourmand G. Pharmacokinetics, efficacy, and safety of Iminoral compared with
Neoral
in
healthy
volunteers
and
renal
transplant
recipients.Transplant
Proc.,39(4):1214-8, May2007
33. Pourmand G, Ziaee AA, Abedi AR, Mehrsai A, Alavi HA, Ahmadi A, Saadati HR.Role
of PTEN gene in progression of prostate cancer. Urology Journal.,4(2):95-100, Spring
2007[PMID: 17701929]
34. Mehrsai A, Djaladat H, Salem S, Jahangiri R, Pourmand G. Outcome of buccal
mucosal graft urethroplasty for long and repeated stricture repair. Urology, 69(1):1721,Discussion 21, January 2007[PMID: 17270600]
35. Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH,
Nourijelyani K. Comparison of urinary proteins in calcium stone formers and healthy
individuals: A case- control study, UrologiaInternaionalis,76(2):163-8, 2006[PMID:
16493220]
36. Pourmand G.Selective evaluation of two urinary enzymes (NAG and AAP) before and
after unilateral shock wave lithotripsy. ActaMedicaIranica, Vol 44, No 5,: 299-305,2006
37. Djaladat H, Mehrsai A, Rezazade M, Djaladat Y, Pourmand G. Varicocele and
Antisperm Antibody: fact or fiction? Southern medical Journal, 99(1):44-7, January
2006[PMID: 16466121]
38. Djaladat H, Mehrsai A, Saraji A, Moosavi S, Djaladat Y, Pourmand G. Suprapubic
prostatectomy with a novel catheter. J Urol., 175(6):2083-6, June 2006[PMID: 16697808]
39. Pourmand G. Improvement of erectile dysfunction after kidney transplantation, The
role of the associated factors.Urology Journal Vol 3, No 4, Autumn 2006: 240-244
40. Mousavi S, Mehrsai A, Nikoobakht M, Abedi AR, Salem S, Pourmand G.A Giant
congenital posterior urethral diverticulum associated with renal dysplasia.Urol J.,
3(4):247-9, Autumn 2006[PMID: 17559051]
41. Pourmand G. Post transplant infectious complications: A prospective study on 142
kidney allograft recipients. Urology Journal, Vol. 3, No. 1, 23-31, 2006
42. Salsabili N, Mehrsai A, Jalalizadeh B, Pourmand G, Jalaie S.Correlation of sperm
nuclear chromatin condensation staining method with semen parameters and sperm
functional tests in patients with spinal cord injury, varicocele, and idiopathic infertility.
Urol J., 3(1):32-7, Winter 2006 [PMID: 17590850]
43. Pourmand G, Pourmand M, Salem S, Mehrsai A, TaheriMahmoudi M, Nikoobakht M,
Ebrahimi R, Saraji A, Moosavi S, Saboury B.Posttransplant infectious complications: a
prospective study on 142 kidney allograft recipients. Urol J., 3(1):23-31, Winter 2006
[PMID: 17590849]
44. Mehrsai A, Mousavi S, Nikoobakht M, Khanlarpoor T, Shekarpour L, Pourmand
G.Posttransplant infectious complications: a prospective study on 142 kidney allograft
recipients. Urol J., 3(4):240-4, Fall 2006 [PMID: 17559049]
45. Djaladat H, Mehrsai A, Nasseh H, Pourmand G. Synchronous renal fossa recurrence with
bladder metastases due to renal cell carcinoma.Urol J., 2(3):169-70, Summer 2005[PMID:
17602423]
46. Mehrsai A, Djaladat H, Sina A, Salem S, Pourmand G. Buccal mucosal graft in repeat
urethroplasty. Urol J., 2(4):206-10, Autumn 2005 [PMID: 17602431]
47. Pourmand G, Nasseh H, Sarrafnejad A, Mehrsai A, HamidiAlamdari D, Nourijelyani K,
Shekarpour L.Urinary Tamm-Horsfall protein and citrate: A case- contral study of
inhibitors and promoters of calcium stone formation. Urology Journal, 2(2):79-85,
Spring 2005 [PMID: 17629875]
48. Pourmand G. Molecular detection of prostate specific antigen in patients with
prostated cancer or benign prostate hyperplasia the first investigation from Iran.
Iranian Journal of Public Health, Vol. 34(3): 20-26, 2005
49. Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers with
erectile dysfunction benefit from stopping? A prospective study. BJU International,
94(9):1310-3, December 2004 [PMID: 15610111]
50. Pourmand G. Preliminary report of a nationwide case-control study for indentifying
risk factors of tuberculosis following renal transplantation. Transplantation
Proceedings, 37(7): 3041-4, September 2005
51. Nikbin B., Tajik N., Saraji A, Pourmand G, Talebian F., Mehrsai A., Amirzargr A.
Microchimerism& renal tranplantatin: Doubt still persists.IJI. Vol. 1, No. 3, Autumn
2004
52. Mehrsai A, TaghizadehAfshar A, Zohrevand R, Djaladat H, Steffes H, Hesse A,
Pourmand G. Evaluation of urinary calculi by infrared spectroscopy. Urology Journal,
1(3):191-4, Summer 2004[PMID: 17914687]
53. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three
trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004
54. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three
trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004
55. Pourmand G. Comparison between clinical and pathologic staging in patients with
bladder cancer. Urology Journal, Vol. 2, 85-89, Spring 2004
56. Pourmand G. Management of Peyronie’s disease by dermal grafting. Urology Journal,
Vol. 2, 99-102, Spring 2004
57. Pourmand G. Effect of renal transplantation on sperm quality and sex hormone levels.
BJU international, Vol. 92, 281-283, 2003
58. Pourmand G. Effect of grapefruit juice on serum concentration of cyclosporine in
Iranian renal transplant patients. Transplantation Proceedings, 35: 2739-2741, 2003
59. Pourmand G. Outcome of 18 cases of simultaneous kidney and donor- specific bone
marrow transplantation. Transplantation Proceedings, 35: 2761-2762, 2003
60. PourmandG.Omission
of
azathioprine
and
mycophenolatemofetil
in
immunosuppressive regiment in kidney transplantation.Transplantation Proceedings,
35: 2752-2753, 2003
61. Pourmand G. Prevalence of Y chromosome microdeletions in Iranian infertile men.
ActaMedicaIranica, Vol. 41, No.3, 164-169, 2003
62. Pourmand G. Prospective study of microchimerism in renal allograft recipients:
association between HLA DR matching, microchimerism and acute rejection. Kidney
Transplantation, 15:192-198, 2001
63. Pourmand G. Impact of donor nephron mass on outcomes in renal transplantation.
Transplantation Proceedings, 33: 2828-2829, 2001
64. Pourmand G. Evaluation of endourological interventions used to treat urological
complications in 394 kidney recipients. Transplantation Proceedings, 32(3): 524-5, May
2000
65. Pourmand G. Patient blood Glucose levels before and after kidney transplantation.
Transplantation Proceedings, 32(3): 566-8, May 2000
66. Pourmand G. The prevalence of infected stones in the urinary tract and their
relationship to urease positive bacteria. Journal of Nep-urol and transplantation, Vol. 1.
No. 1. (5-8), January 2000
67. Pourmand G. Evaluation of the clinical and urodynamic effects of pygeumafricanum
(tadenan) in the treatement of benign prostatic hyperplasia (BPH). British Journal of
Urology, 1997; 80 (Suppl.2), p.227
68. Pourmand G. Traumatic rupture of penile tunica albuginea: management and impact
on erectile function. British Journal of Urology, 1997; 80 (Suppl.2), p.99
69. Pourmand G. Bacteriuria and extracorporeal shock wave lithotripsy, prophylaxis and
treatment. British Journal of Urology, 1997; 80 (Suppl.2), p.332
70. Pourmand G. Evaluation of acute kidney rejection in 151 recipientsBritish Journal of
Urology, 1997; 80 (Suppl.2), p.147
71. Pourmand G. Extracorporeal shock wave lithotripsy in horseshoe kidneysBritish
Journal of Urology, 1997; 80 (Suppl.2), p.333
72. Pourmand G. Congenital Ureteric Valve associated with renal dysgenesis. British
Journal of Urology, Vol.61. 362-363, April 1988
73. Pourmand G. Evaluation of surgical complications in 151 transplanted kidneys.
Transplant proceedings, 1998
74. Pourmand G. Twenty two Cases of simultaneous heart, liver and kidney transplant
from established brain dead patients. Transplant proceedings, 30 773-774, 1998
75. Pourmand G. Lipids and lipoproteins alteration after renal transplantation.
Nephrology Dialysis Transplantation. 12 (1): 233-4, January1997
76. Pourmand G. Nocardiosis: Report of four cases in renal transplant recipients.
Transplantation Proceedings Vol. 27, No.5:2731-2733, October 1995
77. Pourmand G. Urinary tract obstruction following ESWL. Acta Medical Iranica, Vol.
32: No. 1 (22) 1-11, 1994
78. Pourmand G. Laparoscopy in Urology. Acta Medical Iranica, Vol. 32, 101-109, 1994
79. Pourmand G. Kibrick test in Vasovasectomy, ACTA Medical IRANICA, 1992
80. Pourmand G. Donor polar kidney arteries: experience with 10 cases among 140 livingrelated kidney transplants. Transplantation Proceedings. 24(5):1867, October 1992
81. Pourmand G. The mineral compositions of 103 stones from Iran. British Journal of
Urology, Vol. 55 No.5, October 1983
82. NOTE: Pourmand G. Urinary infection before and after prostectomy. Saudi Arabia
Journal (In Press)
a. Farsi
83. Pourmand G. The Effect of Renal Transplantation on Improvement of Erectile
dysfunction in hemodialysis patients.Urmia Medical Journal. Vol 18, No 3, Fall 2007:
567-571
84. Pourmand G. Design, fabrication and test of a new self-retaining, standing, adjustable
surgical retractor for abdominal and thoracic surgical operations.Hakim Research
Journal 2007; 9(4): 37-45
85. Pourmand G. Post-Transplantation infectious complication in Iranian kidney
recipients: A prospective study of 142 patients. Scientific Journal School of Public
Health and Institute of Public Health Research, Vol. 4, No. 2, Summer 2006
86. Pourmand G. Response of T cell cytokines to low level He-Ne laser irradiation invitro:
can low level lasers prevent chronic graft rejection? Lasers in Medicine, Vol.4, No. 4,
Spring 2006
87. Pourmand G. Evaluation of bone mineral density in patients with urolithiasis.
Hormozgan Medical Journal No 3, Fall 2005: 157-162
88. Pourmand G. Hematospermia. Medical Journal of Tehran Medical School, Spring 2004
89. Pourmand G.Clinical and laboratory findings of CMV infection in renal transplant
recipients in Sina Hospital.Journal of infectious and tropical diseases.2003:37-39
90. Pourmand G. Post kidney transplantations: Infectious complications. Today Iranian
Journal of Urology, 16-23, 2003
91. Pourmand G. Genes and gene therapy in oncourology. Iranian Journal of Urology,
Spring 2001
92. Pourmand G. Success rate of ICSI in nonobstructiveAzoospermia. No. 32: 183-189,
Autumn 2001
93. Pourmand G. Evaluation of frequency or aggravation of diabetes mellitus after renal
transplantation in Sina Hospital. Iranian Journal of Endocrinology &Metabolism , 3,
No. 2, Summer 2001
94. Pourmand G. Micro-chimerism in allograft renal recipients: A prospective study.
Iranian Journal of Urology, Winter 2001
95. Pourmand G. Comparison of sperm quality and sex hormone levels in patients before
and after renal transplantation. Iranian Journal of Endocrinology & Metabolism, 2,
No. 4, Winter 2000
96. Pourmand G. Splenosis presenting as an adrenal massIranian Journal of Urology, No.
27, Fall 2000
97. Pourmand G. Impact of varicocelectey on strict morphology criteria. Iranian Journal of
Urology, No. 25, Spring 2000
98. Pourmand G. Role of urease positive bacteria on infected urinary tract stone
Formation.Journal of infectious and tropical diseases, Winter 1996: 34-39
99. Pourmand G. The 1st clinical report of ESWL in Iran. Journal of Medical Council,
1992
100.
Pourmand G. Pheochromocytomain bladder, Medical Journal of Islamic Republic
of Iran, Vol.21. 75-77:1988
101.
Pourmand G. Spectroscopy of renal stones in Iran. Journal of Iranian Medical
Council. Vol.9.14-24:1984
102.
Pourmand G. Congenital Urethral Diverticulum along with paraurethral diver.
Journal of Tehran Medical School, Vol. 5-6, 95-98, 1981
103.
Pourmand G. Ectopic ossification as a nidus for renal stone. Journal of Iranian
Medical Council, Vol 6.467:1978

Books
1. Pourmand G. Iranian Textbook of Urology. Shahid Beheshti University Publications,
2007
2. Pourmand G. Essential Urology. Tehran University of Medical Sciences Publications,
2003
3. Pourmand G. Organ Transplantation. Special Diseases Center, 2003
4. Pourmand G. Organic Causes of Male Impotency. Tehran University of Medical
Sciences Publications, 1994

Presentations in National & International Meetings
1. September 7-10, 2011: 1st Meeting of EAU Section of Urolithiasis (EULIS), London
– UK
a. Stones in the East (Poster)
b. Training the academic stone doctor
c. Epidemiology of stone disease in developing countries
2. July 13, 2011: Seminar on Executive Solutions for Cancer Control in Iran, Solutions
offered by TUMS Urology Research Center, Vienna – Austria (Poster)
3. May 14-19, 2011: Annual Meeting of the American Urological Association,
Washington DC – USA
a. HER2/NEU overexpression as a prognostic factor in urothelial carcinoma of
the bladder: A comparative analysis
b. Role of steroid hormone receptors on formation and progression of bladder
carcinoma
c. Serum uric acid ad an independent risk factor for erectile dysfunction
4. May 3-6, 2011: 14th Congress of Iranian Urological Association, Tehran – Iran
a. A prospective evaluation of graft rejection episodes by Doppler resistance
indices in kidney recipients
b. Augmentation of Chimerism by donor bone marrow cells infusion in kidney
allograft recipients
c. Dyslipidemia in kidney transplantation recipients: Evaluation of risk factors
d. Extraperitoneal orthotopic radical cystoprostatectomy approach can improve
the postoperative morbidity
e. Is antithymocyte therapy considered as risk factor for post kidney
transplantation cytomegalovirus infection?
f. Is there a relation between post-kidney transplantation antithymocyte globulin
therapy and wound healing disturbance?
g. Modified cut-off point of total prostate-specific antigen and free-to-total
prostate-specific antigen ratiofor detecting prostate cancer: sensitivity and
specificity evaluation
h. Sandwiched tunnel: A novel antireflux ureterointestinal pouch anastamosis
approach with easier endourologic access
i. Serum calcium as a protective marker against prostate cancer: Role of
associated factors
j. Serum calcium concentration, sex steroid hormones and risk of prostate
cancer: A prospective evaluation
k. Serum uric acid as a risk predictor for erectile dysfunction severity
l. Sex hormones, sexual activity and risk of prostate cancer: A multicenter study
m. Sex steroid hormones play pivotal roles in the diabetes mellitus effects on
prostate cancer risk
n. Testosterone administration effects on sexual function in aging males with
symptoms of late-onset hypogonadism and normal or subnormal Testosterone
level: A comparative analysis
o. Would calcium consumption lead to a reduction in the prevalence of prostate
cancer?
5. March 18-22, 2011: 26th Annual EAU Congress, Kidney transplantation: Basic
research and technical risks , Vienna – Austria (Poster)
6. April 09, 2011: Nexavar RCC Expert Workshop, Paris – France
7. November 07-11, 2010: Women's Congress, Role of male factor in infertile patients,
Tehran – Iran
8. November 02, 2010: Educational workshop on devising local values for specialized
urological services, Tehran – Iran
9. September 27-29, 2010: Workshop for familiarizing new residents of Sina Hospital
(2010-2011), Tehran – Iran
10. October 18-21, 2010: The 12th Congress of the Middle East Society for Organ
Transplantation, Tunis – Tunisia
11. June 30 – July 02, 2010: ISN Nexus Symposium on Fibrosis & the Kidney, CKD
prevalence in rural population of over 30 years in Shahreza in 2009,Geneva –
Switzerland
12. June 24, 2010: Sanofi-Aventis Prostate/Breast Cancers Standalone, Panel & Case
Discussion, Budapest – Hungary
13. June 22, 2010: Iranian Cancer Association, Panel & Case Discussion,Tehran – Iran
14. May 13-16, 2010: The26th Iranian Congress of Radiology, Tehran – Iran
a. Renal Masses
b. Panel: Diagnostic clues and pitfalls in Uroradiology
15. May 13-16, 2010: 13th Congress of Iranian Urological Association, Tehran – Iran
a. Serum triglyceride concentration and prostate cancer risk: A multicenter
study
b. Evaluation of serum high-sensitivity C-reactive protein in kidney transplant
recipients within the first six months after transplantation
c. Evaluation of urologic and non-urologic complications of cesarean section
delivery compared to natural vaginal delivery in patients referred to Arash
Hospital
d. Evaluation of underlying risk factors for delay in referring children with
urethral tract infections (Utis) to hospitals
e. Her-2 oncogen expression and risk of bladder cancer: Role of associated
factors
16. May 2010: The34thAnnual Congress of the Iranian Surgeons Society& the 9th Iranian
Organ Transplantation Scientific Congress, Tehran – Iran
a. Round table: Preparing and removing transplanting organs
b. Imaging in Organ Transplantation
17. April 16-20, 2010: Annual EAU Congress, Barcelona – Spain
a. PTEN gene mutation & primary prostate cancer progression
b. Participation in the Joint Session: Low risk prosthetic carcinoma: Surgery or
surveillance?
18. 2008: Iranian Congress of Renal Transplantation
a. Management of ureteral urologic complications: experience after 1000 kidney
transplantation
b. Does PTN gene play a role in prostate cancer progression?
c. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow
transplantation
d. Does donor nephron mass have any impact on graft survival?
e. Microchimerism and renal transplantation:Doubt still persists.
f. Surgical techniques in treatment of urologic complication after renal
transplantation
g. Pelvic Nerve neuropathy after kidney transplantation
h. The effect of successful renal transplantation on erectile dysfunction
i. Omission
of
azathioprine
and
mycophenolatemofetil
in
immunosuppressive regimen in kidney transplantation
j. Effect of renal transplantation on sperm quality and sex hormone level
k. The outcome of renal transplantation in 28 patients receiving kidneys with
multiple renal vessels
l. Effect of donor bone marrow cells infusion on alloimunization and kidney
allograft outcome
m. Infectious complications in 142 Persian kidney transplant recipients during
one-year follow-up
19. 2008:The 7th Congress of Iran Organ Transplantation
a. The effect of Successful Renal Transplantation on erectile dysfunction.
b. The effect of Successful Renal Transplantation on Sperm quality and sex
hormones level.
c. Post kidney transplantation hepatitis C virus and its impact on graft and
patient survival.
d. Does donor nephron mass have any impact on graft survival?
e. Surgical techniques in treatment of urologic complication after renal
transplantation.
f. Infectious complications in 142 persiankidney transplant recipients during one
year follow-up
g. Effect of living unrelated donor bone marrow cells infusion on kidney allograft
function.
h. Ureteroscopic
management
of
urological
complications
after
renal
transplantation.
20. 2008: The11th Congress of Iranian Urological Association
a. Serum Selenium level and prostate cancer: A case-control study
b. The effect of low level he-ne laser radiation (4 j/cm2) 632.8 nm on the
secretion of effective cytokine on chronic graft rejection: An invitro study
c. Effect of living unrelated donor bone marrow cells infusion on kidney
allograft function
d. Management of ureteral urologic complications: experience after 700 kidney
transplantation
e. Post kidney transplantation hepatitis C virus and its impact on graft and
patient survival
f. The effect of calcium,magnesium,zinc and copper in blood and seminal
plasma on semen parameters of spinal cord injured men
g. Serum Leptin level and premature ejaculation: A case-control study
h. TUL or ESWL is the approach of choice for upper ureter stones management:
a comparative study
21. 2008: The23rd Annual EAU Congress, Extracorporeal shock wave lithotripsy in
adults: results and short-term complications, Milan – Italy
22. 2008: AUA 2008 Annual Meeting (USA)
a. Extracorporeal shock wave lithotripsy and its effect on renal
function,assessed by 99m Technetium Dethylene-Tiamine-Pentaacetic acid
Scintigraphy
b. The effect of successful renal transplantation on erectile dysfunction
a. 2008: The 2nd International Congress of Medical Ethics in Iran, Ethical
consideration for kidney transplant from deceased patients
23. 2007: The 29th Congress of the Societe International d’urologie (SIU) (Paris –
France)
a. Serum selenium level and prostatecancer : A case-control study
b. TUL or ESWL is the approach of choice for upper ureter stones management:
a comparative study
c. The effect of successful renal transplantation on erectile dysfunction.
24. 2007: EAU 1st Eastern Mediterranean Meeting (Antalya – Turkey)
a. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow
transplantation
b. Serum selenium level and prostate cancer: A case –control study
c. Does PTN gene play a role in prostate cancer progression?
d. Anabolic androgenic steroids effects on early morbid symptoms after open
prostatectomy
e. Prospective study of michrochimerism in renal allograft recipients:
Association between HLA-DR matching,michrochimerism and acute rejection
f. Effect of renal transplantation on sperm quality and sex hormone level
g. The effect of low level He-Ne laser radiation (4J/cm2)632.8nm on the
secretion of effective cytokine on chronic graft rejection-an in vitro study
h. Microchimerism and renal transplantation: Doubt still persists
i. Post kidney transplant hepatitis C virus and its impact on graft and
patient survival
j. Does donor nephron mass have any impact on graft survival?
k. Urinary tamm-horsfall protein and other inhibitors and promotors of calcium
stone formation: A case-control study
l. TUL or ESWL is the approach of choice for upper ureteral stones
management: A comparative study
m. Evaluation of sperm nuclear chromatin condensation in infertile patients
with spinal cord injury varicocele and healthy individuals
25. 2007: The 13th Congress of The European Society for Organ Transplantation (ESOT)
a. Surgical techniques in treatment of urologic complication after renal
transplantation
b. Does donor nephron mass have any impact on graft survival?
c. Improvement of erectile dysfunction after kidney transplantation the role of
associated factor
d. Effect of living unrelated donor bone marrow cells infusion of kidney allograft
function
e. Post kidney transplant hepatitis C virus and its impact on graft and patient
survival
f. Role of resistive index measurement in diagnosis of acute rejection after renal
transplantation
26. 2007:The19th Asia Pacific Cancer Congress, Screening for prostate cancer, Tehran –
Iran
27. 2007: The 44th ERA-EDTA Congress (Barcelona, Spain)
a. Prevalance of metabolic abnormalities of calcium in pateints with urinary
stone in south Iran
b. Effect of renal transplantation on sperm quality and sex hormones level
c. Prospective study of microchimerism in renal allograft recipients: Association
between HLA DR matching, microchimerism and acute rejection.
d. Role of resistive index measurement in diagnosis of acute rejection after renal
transplantation .
e. Ureteroscopic
management
of
urological
complications
after
renal
transplantation
28. 2007: The7th International Congress on Obstetrics and Gynecology,Nanogyncology,
Iran
29. 2007: The 11th International Congress of Nephrology, Dialysis and Transplantation,
Iran
a. Effect of living unrelated donor bone marrow cells infusion on kidney
allograft function
b. Post kidney transplant hepatitis C virus and its impact on graft and patient
survival
30. 2007: The 10th Iranian Urological Ass. Congress, TUL or ESWL is the approach of
choice for upper ureteral stones management: A comparative study
31. 2007:Vascular Surgery and Diabetics Mellitus Congress, Diabetes and kidney
transplantation, Tehran – Iran
32. 2007:XLIV-EDTA Congress (Spain), Prospective study of microchimerism in renal
allograft recipients: Association between HLA DR matching, microchimerism and
acute rejection
33. 2006:The10th Congress of the Middle East Society for Organ Transplantation, Kuwait
a. The effect of successful renal transplantation on erectile dysfunction
b. Surgical techniques in treatment of urologic complication after renal
transplantation
34. 2006: The 28th Congress of the SocieteInternationaled’Urologie, South Africa
a. Seminal plasma magnesium and premature ejaculation: a case-control study
b. Does PTEN gene play a role in prostate cancer progression?
c. The impact of nandrolone on post prostatectomy bothersome symptoms
d. Comparison of urinary proteins in calcium stone formers and healthy
individuals: a case-control study
e. Ureteroscopic management of ureteral injury during gynecological surgery
f. Preoperative
corporal
biopsy can predict
postoperative results
in
venoocclusive erectile dysfunction
g. The relationship between lipid profile and erectile dysfunction
35. 2006: The 21st Congress of the European Association of Urology (EAU),
Microchimerism and Renal Transplantation: Doubt Still Persists, Paris – France
36. 2006: The 31st Congress of the Federation-of-European-Biochemical-Societies
(FEBS) Istanbul, Turkey
a. Prevalence intron 1 duplication among patients susceptible to primary
hyperoxaluria type 1 in Iran
37. 2006:
The10th
Iranian
Annual
Congress
of
Nephrology,
Dialysis
and
Transplantation
a. A nationwide case-control study for identifying the risk factors for
tuberculosis following renal transplantation
b. Guillan - Barre Syndrome after renal transplantation
38. 2006: The Iranian Medical Students Nano Congress Seminar. Applied Nano Medicine
39. 2006: The 43rd Annual congress of the European-Renal-Association/ EuropeanDialysis-and-Transplant Association (ERA-EDTA) Glasgow, Scotland
a. Outcome of 18 cases of simultaneous kidney and donor- specific bone marrow
transplantation.
b. Endourological interventions used to treat urological complications in 700
kidney recipients.
c. Prospective study of microchimerism in renal allograft recipients.Association
between HLA DR matching, microchimerism and acute rejection
d. Prevalance of metabolic abnormalities of calcium in pateints with urinary
stone in south Iran
e.
Omission of azathioprine and mycophenolatemofetil in immunosuppressive
regimen in kidney transplantation
f. Incidence of post renal Transplantation hyperlipidemia and its long term
impact on patients and graft survival
g. Effect of renal transplantation on sperm quality and sex hormones level
40. 2005:The 42ndAnnual Congress of the European-Renal-Association/ EuropeanDialysis-and-Transplant Association (ERA-EDTA)Istanbul,Turkey
a. .Effect of donor kidney mass on graft survival in renal transplantation
b. Prevalance of metabolic abnormalities of calcium in patients with urinary
stone in south Iran
c. Prospective study of microchimerism in renal allograft recipients: Association
between HLA DR matching, microchimerism and acute rejection.
d. Effect of renal transplantation on sperm quality and sex hormones level
41. 2005: Nano Medicine in Obstetrics & Gynecology
42. 2005: The General Secretary of Energy in Endourology
43. September 13 – 15, 2005:The 9th European Symposium on Urolithiasis, Rotterdam –
The Netherlands
a. The Infrared Spectroscopic Analyses of 241 Iranian Urinary Stones
b. Comparison of Urine Culture Proximal to Stone with Preoperative Urine
Culture
44. March 16 – 19, 2005:The XXth Congress of the European Association of Urology,
Istanbul – Turkey
a. Catherter-free suprapubicprostatectmy: a novel technique
b. Effect of donor kidney mass on graft survival in renal transplantation
c. Do cigarette smokers with erectile dysfunction benefit from quitting?
d. Selective Evaluation of two urinary enzymes (NAG and AAP) before and after
unilateral shock wave lithotripsy
45. October 3 – 7, 2004: The XthCongress of the SocieteInternationaled, Urologie (SIU),
Hawaii – USA
a. Urinary Tam-Horsfall protein, inhibitors and promoters of calcium stone
formation: a case- control study
b. Ras and p53 gene mutations in Iranian bladder cancer
c. Erectile dysfunction in patients with coronary artery disease
d. Role of resistive index measurement in diagnosis of acute rejection after renal
transplant
e. The effect of electroejaculation on the quality and quantity of seminal fluid
and sperm of spinal cord injured (SCI) men in comparison with normal fertile
men
f. Endourological interventions used to treat urologicalcomplications in 700
kidney recipients
g. VII- Clinical correlation of unilateral testicular hypotrophy and semen quality
h. Relation between erectile dysfunction and blood lipids: a case- control study
46. 2004: AUA 2004 annual meeting (San Francisco,CA)
a. Bone mineral density evaluation in urolithiasis
47. 2004:The 9th International Congress of the Middle East society for organ
transplantation, Ankara – Turkey
a.
Omission of azathioprine and mycophenolatemofetil in immunosuppressive
regimen in kidney transplantation
b. Preliminary report of a nationwide case control study for identifying the risk
factors of tuberculosis following renal transplantation
c. Microchimerism and renal transplantation: doubt still persists
d. To study the risk factors for post- transplant diabetes mellitus
48. April 22 – 24, 2004:The 9th International Congress of the Middle East Society for
Organ Transplantation, Tehran – Iran
a. Post kidney transplant Hepatitis C virus and Its impact on graft and patient
survival
b. Surgical Techniques in Treatment of Urologic Complications
c. Kidney transplantation and diabetes mellitus
49. 2003: Genetics in urology. The 1st Iranian International Congress on Medical
Genetics
50. 2003: Arbiter in the 9thRazi Medical Research Festival
51. September 21 – 24, 2003:The 11th Congress of the European Society for Organ
Transplantation,VeniceLido – Italy
52. September 20 – 22, 2003:The 13th Congress of the European Transplant
Coordinators Organization,VeniceLido – Italy
53. 2003:EUA,Madrid – Spain
54. 2003:EDTA Congress,Denmark
55. 2002: Arbiter in the 8thRazi Medical Research Festival
56. 2002: Physician and forensic medicine. The International Congress on Forensic
Medicine
57. September 8 – 12, 2002:The 26th Congress of the SocieteInternationale d’ Urologic,
Stockholm – Sweden
a. Prospective study of microchimerism in renal allograft recipients.Association
between HLA DR matching, microchimerism and acute rejection
b. Kidney transplantation and diabetes mellitus
c. Effect of renal transplantation on sperm quality and sex hormones level and
sexual function
d. Evaluation of endourological intervention used to treat urological
complications in 394 kidney recipients
e. Effect of sex of donor blood group and age difference between donor and
recipient on early acute rejection in 370 renal transplantations
58. October 21 – 24,2002:The VIII International Congress of the MESOT, Oman
59. September 8 – 12,2002: The 26thSIU, Stockholm – Sweden
60. September 13-15, 2001:The 9th European Symposium on Urolithiasis, Rotterdam –
The Netherlands
a.Comparison of Urine Culture Proximal to stone with preoperative urine culture..
b. The Infrared Spectroscopic Analyses of 209 Iranian urinary stones.
C. Prevalence of metabolic abnormalities of Calcium in patients with urinary stone in
South of Iran.
d.Effect of nasal desmopressin on the treatment of acute renal colic.
61. 2001:International Congress of the Middle East Society for Organ Transplantation,
Stockholm – Sweden
a. Patient blood glucose levels before and after kidney transplantation
b. Incidence of post renal Transplantation hyperlipidemia and its long term
impact on patients and graft survival
c. Evaluation of endourological interventions used to treat urological
complications in 394 kidney recipients
d. The outcome of renal transplantation in 23 patients receiving kidneys with
aberrant or accessory vessels
e. Impact of donor Nephron mass on outcome in renal transplantation
f. Alternations in standard immunosuppressive regimen in kidney transplanted
patients and its effects on graft survival
g. Post kidney transplant hepatitis C Virus and its impact on graft and patient
survival
62. 2001-02: Workshop on Scientific Writing
63. 2001:25 years in Renal Transplantation, Ankara – Turkey
64. 2001:The European Association of Organ Transplantation, Lisbon – Portugal
65. 2001:Premature Ejaculation. The 5th Iranian Urological Association Congress
66. 2001: Gene therapy in Urological Cancers. The 6th Iranian Urological Association
Congress
67. 2000: Infection in children. The Iranian Congress on Urinary Infection in Newborns
and children
68. 2000:Middle East Organ Transplantation Congress, Beirut – Lebanon
69. 1999:Middle East Organ TransplantationCongress, Isfalan – Iran
70. 1999:The 8thUrolithiasis Symposium, Parma – Italy
71. 1999:The First Iranian Organ Transplantation Congress, Iran
72. 1999:The 23rd Congress of SIU, Sydney - Australia
73. 1999:The 4th International Urological Congress, Iran
74. 1999:The 25th Congress of the SocieteInternationale d’ Urologie, Stockholm –
Sweden
a. Chromosomal studies of 222 infertile males in Tehran
b. Intra-Cytoplasmic Sperm Injection for Non-obstructiveAzoospermia
75. 1998:Update in Nephrology Course, Dubai – UAE
76. 1997:The 4th Turkish Organ Transplant, Ankara – Turkey
77. 1997:The 24th Congress of the SocieteInternationale d’ Urologic, Montreal – Canada
a. Evaluation of Acute kidney Rejection in 151 Recipients
b. The Incidence of Infected Stones and their Relationship to Urease Positive
Bacteria
78. 1997:The 15th World Congress on Endourology, Edinburgh – Scotland, UK
a. Evaluation of the Clinical and Urodynamic Effects of pygeumAfricanum
(TADENAN) in the Treatment of Benign Prostatic Hyperplasia (BPH)
b. Utilizing of N-Acetyl-Glucosaminidase (NAG) &AlaninAminopeptidase (AAP)
Urinary Enzymes to Evaluate Kidney Parenchymal Injury Following
Extracorporeal Shock wave Lithotripsy (ESWL)
79. 1997:Nuclear Scintigraphy EAU Congress, Paris – France
a. The Earty Effect of Electromagnetic Lithotripsy on Renal Function Assessed
by Nuclear Scintigraphy EAU Congress
b. Traumatic Rupture of Penile Tunica Albuginea: Management and impact on
Erectile Function, EAU Congress Pris, France
80. 1996:The Xllth EAU Congress, Paris – France
81. 1996:Visiting the Nephrology Department of PISA University, Italy
82. 1996:The 5th Middle East Society for Organ Transplantation,Lipid and Lipoproteins
alterations after Renal Transplantation, Limassol – Cyprus
83. 1994:Xth World Congress of Endourology,Louisiana – USA
a. Bacteriuria and Extracorporeal shock wave lithotripsy Prophylaxis and
treatment
b. Extracorporeal shock wave Iithotripsy in Horseshoe kidneys
84. 1992:Xth Congress European Ass. Urology,Early Repair of Urological injuries
following pelvic Surgery, Italy
85. 1992:The Xth Congress of Eurpoean Ass. Urology, Italy
86. 1991:Ethics, Justice & Commerce in Organ Transplantation, Munich – Germany
87. 1991:SThe 22nd International Urological Congress,Complex Post. Urethral Stricture,
Servilla - Spain
88. 1990:Middle East Organ Transplantation,Urological Complications in Transplanted
Kidneys, Mesot–Kuwait
89. 1990:The 2nd International Urological Seminar,Tubed Versus Tubeless Pyeloplasty,
Tabriz – Iran
90. 1989:The 3rd Annual Avicenna Medical Congress,Management of Urological
Complications in Kidney Transplant, Tehran – Iran
91. 1989:Lithotripsy Meeting, Dubai – UAE
92. 1988:American Urological Association (Annual meeting), Dallas – USA
93. 1988: The 2nd Annual Avicenna Medical Congress,Ureteral folding versus Ureteral
tailoring in management of megaureter, Tehran –Iran
94. 1987: The 1st International Urological Seminar,Omental Graft in complicated
vesicovagingl fistulae, Tehran – Iran
95. 1987: The 1st International Urological Seminar,Evaluation of
TranspublicUrethroplasty, Tehran – Iran
96. 1986: The 1st Annual Avicenna Medical Congress,Ureteral folding versus Ureteral
tailoring in management of megaureter, Iran
97. 1977:The British Association of Urological Surgeons, Aberdeen – UK
Grants:
Completed Grants

Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy
volunteers and Renal Transplant recipients (September 4, 2005 – July 10, 2006) with
ZahraviPharma Company
Pending Grants

Result of prostate biopsy on the basis of Total PSA (free PSA , PSA D) accompany
with prostate cancer risk factors , in Iranian patients ( September 23, 2007 up to
now) withMinistry Of Health and Medical Education
Awards:

The 2ndRoyan International Research Award

Special Diseases Foundation “Letter of Appreciation”

Shiraz Janbazan Organization “Letter of Appreciation”, Supervisor of the Examining
Board (Ministry of Health and Medical Eduacation)

The 7thRazi Festival Award (National Research Center of Medical Sciences), First
Rank – Clinical Sciences

The 11thRazi Festival Award, First Rank – Invention, Innovation, Novelty and
Scientific Hypothesis
Competencies:

Language
o Moderate English